Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: analysis of a multicentre prospective cohort
L E López-Cortés,J M Cisneros,F Fernández-Cuenca,G Bou,M Tomás,J Garnacho-Montero,A Pascual,L Martínez-Martínez,J Vila,J Pachón,J Rodríguez Baño,GEIH/REIPI-Ab2010 Group,Antonio Sánchez Porto,Luis Vallejo,Begoña Fernández Pérez,José Carlos Villar Chao,Belén Padilla Ortega,Emilia Cercenado Mansilla,José Javier García Irure,Alfonso del Arco Jiménez,Javier de la Torre Lima,Concepción Gimeno Cardona,Vicente Abril,Joseph Vilaró Pujals,Marian Navarro Aguirre,José Antonio Jiménez Alfaro,Carlos Reviejo Jaca,Pilar Marín Casanova,Francisca Guerreo,Teresa Nebreda Mayoral,María José Fernández Calavia,Esperanza Merino de Lucas,Alfredo Zorraquino,Eugenio Garduño Eseverri,Luis López Sánchez,Ana Fleites Gutiérrez,Azucena Rodríguez Guardado,José María García-Arenzana Anguera,Serafín López Palmero,Manuel Rodríguez Maresca,Fernando García Garrote,José Varela Otero,Elisa Vidal Verdú,Fernando Rodríguez López,Fernanda Pardo Sánchez,E Ferrer Vizoso,Mercé Gurgui,Roser Pericas,Pedro María Olaechea Astigarraga,Rafael Ayarza Igartua,María Dolores Maciá Romero,Enrique Ruiz de Gopegui Bordes,María Isabel Sánchez Romero,Jesús García Mata,María José Goyanes,José Hernández Quero,Trinidad Escobar Lara,Frederic Ballester Bastardie,Simona Iftimie,María Isabel Galán Navarro,María Luz Cádiz Gurrea,Carmen Amores Antequera,Montserrat Gómez,Carmina Martí Salas,Jordi Cuquet Peragosa,Susana Hernando Real,Pablo A Carrero González,María Angeles Pallarés González,Sergio Rodríguez Fernández,Miquel Pujol Rojo,Fe Tubau,Enrique Nuño Alvarez,María Ortega Torres,Salvador Giner Almaraz,Elena Hortelano,Fernando Chaves Sánchez,Ana García Reyne,Juan Pablo Horcajada Gallego,Concha Segura,Gema Sierra Dorado,Raquel Yano Escudero,María Elena Dorta Hung,Cristóbal del Rosario Q
DOI: https://doi.org/10.1093/jac/dku233
Abstract:Background: Treatment of multidrug-resistant Acinetobacter baumannii (MDRAB) infection presents a challenge because of the scarcity of available options. Even though combination therapy (CT) is frequently used in clinical practice, data are needed to support its use instead of monotherapy (MT). Methods: A prospective observational study was conducted in 28 Spanish hospitals. Patients with sepsis caused by MDRAB, defined according to strict criteria, and who received active antibiotic treatment (according to in vitro susceptibility testing) for at least 48 h, were included. The main outcome variable was all-cause 30 day mortality after initiation of targeted therapy. Multivariate analysis, including a propensity score (for receiving CT), was performed by Cox regression. Results: One hundred and one patients were included in the analysis; 68 (67.3%) received MT and 33 (32.7%) received CT. Pneumonia was the most common infection (50.5%), 68.6% of cases being associated with mechanical ventilation. Colistin (67.6%) and carbapenems (14.7%) were the most common drugs used in MT; colistin plus tigecycline (27.3%) and carbapenem plus tigecycline (12.1%) were the most frequent combinations. Crude 30 day mortality was 23.5% and 24.2% for the MT and CT groups, respectively (RR = 1.03; 95% CI 0.49-2.16; P = 0.94). Multivariate analysis of 30 day survival showed no trend towards reduced 30 day mortality with CT (HR = 1.35; 95% CI 0.53-3.44; P = 0.53). Subgroup analysis showed similar results. Conclusions: Our data do not support an association of CT with reduced mortality in MDRAB infections. More data for specific types of infection and combinations are needed.